Rylan DeStefano

CURE® highlights some of the most significant lung cancer news of 2023 in honor of Lung Cancer Awareness Month.

Recent years have brought more targeted agents to the frontline treatment for patients with chronic lymphocytic leukemia.

From Suzanne Somers’ death from metastatic breast cancer and Julia Louis-Dreyfus discusses her outlook on life post-diagnosis, here is what’s happening in the oncology space this week.

Two phase 3 randomized trials focused on evaluating the safety and efficiency of anamorelin to treat adult patients with advanced non-small cell lung cancer linked with weight loss and cachexia.

One expert explained how care team aspects such as open dialogue, support and validation can help to inform patients with MPN about psychosocial needs that tend to be unmet.

In honor of Liver Cancer Awareness Month, CURE® highlighted some of the most impactful liver cancer developments from 2023.

As Georgetown women’s basketball couch Tasha Butts died from cancer and “The Walking Dead” actor Erik Jensen revealed cancer diagnosis, here is what’s happening in the oncology space this week.

In a recent study, obesity was linked to an increased risk of recurrence for patients with HR-positive, early-stage breast cancer.

As Susan Sullivan discussed her lung cancer diagnosis and the FDA discusses banning specific hair straightening products due to long-term health effects, here’s what’s happening in the oncology space this week.

A phase 1 trial is being conducted to evaluate the combination of PT886 and Keytruda in patients with claudin 18.2 positive gastric or gastroesophageal junction (GEJ) adenocarcinomas.

The benefit of neurofeedback by a closed-loop brain-computer interface was prominent when treating chemotherapy-induced peripheral neuropathy in patients with breast cancer.

A new phase 1 trial is testing their first patients with STAR-LLD in the treatment of patients with multiple myeloma.

From Julia Louis-Dreyfus opening up about her breast cancer experience to Dolph Lundgren discussing his experience, here’s what’s happening in the cancer space this week.

Exercise can help empower patients with cancer and boost their overall health, though on difficult days, it is equally important that patients give themselves grace, an expert said.

A recent phase 3 trial revealed that the primary endpoint was met with Keytruda for patients with localized muscle-invasive urothelial carcinoma and locally advanced urothelial carcinoma.

In the recent AUGMENT-101 trial, revumenib met the study goals of complete remission in patients with acute myeloid leukemia or acute lymphoid leukemia.

A new Phase 1B/2 trial treated patients with acute myeloid leukemia (AML) in a drug regimen combination of Annamycin and Ara-C.

Onvansertib either alone or with standard of care many benefit patients with metastatic pancreatic ductal adenocarcinoma and those with pretreated SCLC.

The FDA granted fast track designation for a new inhibitor to treat patients with advanced or metastatic HR-positive, HER2-negative breast cancer.

As Len Goodman’s cause of death was announced and LSU defenseman Greg Brooks announces rare form of brain cancer, here is what’s happening in the oncology space this week.

After receiving pelvic radiotherapy, cancer survivors could live with low-grade chronic inflammation for up to 20 years post-treatment, according to an expert.

CURE shares photos from patients with cancer who posted their animals or pets that took the role of a support system during cancer.

An expert sat down with CURE® and discussed how stem cells are collected before a patient with myeloma undergoes a stem cell transplant.

Patients with Lynch syndrome who partake in regular and aerobic exercise can reduce their chances of receiving a diagnosis of colorectal cancer.

Patients with lung cancer undergoing anatomic lung resections often had one day home return after completing the surgery, but those with a lower socioeconomic status were less likely to leave the hospital the day after surgery.

The PALLAS trial analyzed the impact of BMI in patients with early hormone receptor positive breast cancer.

As Connor McGregor honors a fan who dies from cancer and Steve Scalise reveals information about his blood cancer, this is what’s happening in the oncology space this week.

CURE looks back on some of the most important stories in the chronic lymphocytic leukemia space from 2023.

The recent FDA approval of Aphexda combined with filgrastim improved the collection of stem cells in patients with multiple myeloma.

In honor of National Childhood Cancer Awareness Month in September, here’s a look back at some of the top pediatric cancer developments from 2023.